ETFs Are Net Sellers of Lantheus (LNTH) on Oct. 22
ETFs were net sellers of Lantheus (LNTH) for the fifth consecutive session on Oct. 22, with $11.7 million sold. The trend began on Oct. 16, totaling $59.6 million sold over five days. LNTH is a radiopharmaceutical company with a market cap of $6.5 billion, reporting TTM revenue of $1.56 billion. The stock trades at a P/E of 24.12 and has returned 49.96% YTD.
How this was made
The 30-second read
Why it matters
The main tradable takeaway is the persistence of net ETF selling over five sessions, which can weigh on near-term demand and technicals, but it is not a fundamental catalyst.
Market read
Traders may monitor whether the outflow streak continues or reverses, but the article provides no new company-specific fundamental information.
What to watch
The article does not show whether LNTH’s underlying fundamentals or guidance changed, nor does it quantify total AUM impact beyond net flow, so the signal may be more about positioning than valuation.
Background
The piece is an ETF flow snapshot for LNTH, detailing net buying versus selling across multiple ETFs and the resulting holding footprint.
Ticker impact
Lantheus (LNTH) saw ETF flows turn negative for a fifth straight session, with net $11.7M sold on Oct. 22.
Likely downside bias as the market prices continued ETF outflows and reduced marginal buying support.
The article reports a multi-day streak of net ETF selling and quantifies the latest day’s net outflow, which can influence short-term liquidity and sentiment even without company fundamentals changing.
Market effects
Could modestly affect sentiment for specialty drug and radiopharma names if ETF outflows reflect broader risk reduction in healthcare sub-industries.
Primarily US-focused via ETF positioning in a US-listed healthcare stock.
Limited, as the catalyst is ETF flow data rather than global macro or cross-border corporate events.
Counterpoint
ETF flow outflows may be driven by index/portfolio rebalancing or risk-factor rotations rather than a view on LNTH fundamentals, so price impact could fade quickly.
Key entities
- companyLantheus Holdings Inc
US radiopharmaceutical company; subject of the ETF flow report.
- ETFAVUV
Largest reported seller by dollar value in the article’s ETF flow breakdown.
- ETFDFAC
Second-largest reported seller by dollar value in the article’s ETF flow breakdown.
